Delivery Order SPE2DB22D2211-SPE2DB25FRPLA

Award Date 1/23/25
Potential Completion Date 1/24/25
Potential Value $10K
Ultimate Awardee
Not listed
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor, for the delivery of BETASERON 0.3 MG KITS. The $17,399.33 firm fixed-price delivery order is part of a larger Indefinite Delivery Contract (IDC) valued at up to $999,999,999.00 held by Amerisourcebergen's parent company, Cencora, Inc., with the DLA Troop Support Medical. This IDC serves as the primary vehicle for Cencora, Inc. to provide a comprehensive...
This federal contract award, identified as SPE2DB22D3016|SPE2DB25FALR1, was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $43,909.67, is for the delivery of BETASERON 0.3 MG KITS, a pharmaceutical product. The contract is a Firm Fixed Price Delivery Order with a completion date of January 30, 2025. This award is part of a larger Indefinite Delivery Contract (IDC) that...
This federal contract award was made by the Defense Logistics Agency (DLA) Troop Support Medical to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $10,905.31 firm fixed price delivery order is for BETASERON 0.3 MG KITS and does not have a set-aside designation, indicating open competition. AmerisourceBergen holds a $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which serves as a primary vehicle for...
This federal contract award was made by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation, for the delivery of BETASERON 0.3 MG KITS. The contract, a firm fixed price delivery order, has a ceiling value of $14,006.81 and an ultimate completion date of March 15, 2024. This award is associated with a larger indefinite delivery contract (IDC) that Amerisourcebergen Drug Corp holds with DLA, valued at up to $999,999,999.00 with a...
This federal contract award, with ID SPE2DX15D1053|SPE2DX25F6ENG, was issued by the Defense Logistics Agency's (DLA) Troop Support Medical division to Amerisourcebergen Drug Corp, a major pharmaceutical distributor. The $51,390.69 Firm Fixed Price Delivery Order is for the supply of BETASERON 0.3 MG KITS, with a period of performance through December 9, 2024. The contract has no set-aside designation, indicating open competition. Amerisourcebergen holds a $999,999,999 Indefinite Delivery...
This federal contract award with ID SPE2DB20D3303|SPE2DB25FY9Z4 was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $20,681.95 firm fixed-price delivery order is for the supply of BETASERON 0.3 MG KITS, a specialty medication. This award is part of a larger Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued at $999,999,999, which serves as a primary vehicle for...
This federal contract award, valued at $12,011.35, was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is a Delivery Order under a broader Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued at $999,999,999 and running through November 2026. The contract provides for the delivery of BETASERON 0.3 MG KITS, a specialty medication, to support military treatment...
The Defense Logistics Agency has awarded Amerisourcebergen Drug Corp, through its Corporate Office division, a firm fixed price delivery order contract valued at $9,790.63 to provide BETASERON 0.3 MG KITS. This delivery order is part of a larger indefinite delivery contract (IDC) awarded solely to Amerisourcebergen Drug Corp, with a potential value of $999,999,999.00 and a performance period through December 31, 2025. The IDC serves as the primary contract vehicle for Amerisourcebergen Drug Corp...
This is a federal contract award from the Defense Logistics Agency (DLA) Troop Support Medical to Amerisourcebergen Drug Corp, a major pharmaceutical distributor. The contract, valued at $25,915.22, is for the delivery of BETASERON 0.3 MG KITS, a specialty medication. The contract is a Firm Fixed Price Delivery Order with a completion date of May 23, 2024. Amerisourcebergen Drug Corp is the prime contractor and no set-aside designation is indicated. This award is part of a larger Indefinite...
This federal contract award was issued by the Defense Logistics Agency (DLA) Troop Support Medical to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $27,031.72, is a delivery order under a larger Indefinite Delivery Contract (IDC) between Amerisourcebergen and the DLA, worth up to $999,999,999 through November 2026. This IDC serves as a primary vehicle for providing a comprehensive range of pharmaceutical products and...
  • SPE2DB22D2211
    Indefinite Delivery Contract
  • SPE2DB22D2211-SPE2DB25FRPLA
    Delivery Order

This federal contract award, with ID SPE2DB22D2211|SPE2DB25FRPLA, was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor. The $10,001.74 firm fixed-price delivery order is for BETASERON 0.3 MG KITS, a pharmaceutical product.

The award is not designated as a set-aside contract. It is part of a larger Indefinite Delivery Contract (IDC) between Amerisourcebergen and the DLA Troop Support Medical, valued at $999,999,999 and running through November 2026. This IDC serves as a primary vehicle for Amerisourcebergen to provide a comprehensive range of pharmaceutical products and medical supplies to support military healthcare programs globally.

Generated 5/21/25, 9:56 AM